Additionally, TXNIP is also a glucose-sensitive gene, and its deletion has been shown to attenuate hyperglycemia-induced endothelial dysfunction and VSMC inflammation during atherogenesis [53, 56]. Here, TXNIP is linked to endothelial dysfunction.